CARA THERAPEUTICS

Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation. Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's most advanced patented compound, CR845, is currently undergoing clinical testing for acute pain and pruritis. This best-in-class compound possesses unique analgesic and anti-inflammatory activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.

#SimilarOrganizations #People #Financial #Event #Website #More

CARA THERAPEUTICS

Social Links:

Facebook

Instagram

Industry:

Biotechnology Health Care Therapeutics

Founded:

2004-07-02

Address:

Shelton, Connecticut, United States

Country:

United States

Website Url:

http://www.caratherapeutics.com

Total Employee:

101+

Status:

Active

Contact:

+1 203 567 1503

Email Addresses:

[email protected]

Total Funding:

472.4 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress

Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

ribon-therapeutics-logo

Ribon Therapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

Current Advisors List

geoffrey-w-smith_image

Geoffrey W. Smith Board of Observer @ Cara Therapeutics
Board_observer

christopher-posner_image

Christopher Posner Member, Board of Directors @ Cara Therapeutics
Board_member
2018-08-01

kevin-crowley_image

Kevin Crowley Board of Directors @ Cara Therapeutics
Board_member
2008-07-01

christopher-moller_image

Christopher Moller Board of Directors @ Cara Therapeutics
Board_member

Current Employees Featured

christopher-posner_image

Christopher Posner
Christopher Posner President & Chief Executive Officer @ Cara Therapeutics
President & Chief Executive Officer
2021-11-01

derek-chalmers_image

Derek Chalmers
Derek Chalmers Co-founder, Chief Executive Officer, President & Director @ Cara Therapeutics
Co-founder, Chief Executive Officer, President & Director

paul-beckett_image

Paul Beckett
Paul Beckett Senior CMC Project Manager @ Cara Therapeutics
Senior CMC Project Manager
2020-01-01

jeffrey-ives_image

Jeffrey Ives
Jeffrey Ives Director @ Cara Therapeutics
Director
2014-07-01

tom-reilly_image

Tom Reilly
Tom Reilly Chief Financial Officer @ Cara Therapeutics
Chief Financial Officer
2020-10-01

michael-e-lewis_image

Michael E. Lewis
Michael E. Lewis Co-founder, Chief Scientific Advisor @ Cara Therapeutics
Co-founder, Chief Scientific Advisor

frederique-menzaghi_image

Frederique Menzaghi
Frederique Menzaghi Chief Scientific Officer, Senior VP Research & Development @ Cara Therapeutics
Chief Scientific Officer, Senior VP Research & Development
2014-07-01

Founder

derek-chalmers_image

Derek Chalmers

frederique-menzaghi_image

Frederique Menzaghi

michael-e-lewis_image

Michael E. Lewis

Stock Details

Company's stock symbol is NASDAQ:CARA

Investors List

devon-park-bioventures_image

Key Employee Changes

Date	New article
2021-11-03	Cara Therapeutics Announces CEO Transition

Official Site Inspections

http://www.caratherapeutics.com Semrush global rank: 4.84 M Semrush visits lastest month: 1.85 K

Host Informations
Whois Informations

Loading ...